APA (7th ed.) Citation

Ubaid, S., Ford, T. J., Berry, C., Murray, H. M., Wrigley, B., Khan, N., . . . Cotton, J. M. (2019). Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial. Thrombosis and haemostasis, 119(7), 1171. https://doi.org/10.1055/s-0039-1688789

Chicago Style (17th ed.) Citation

Ubaid, Salahaddin, et al. "Cangrelor Versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial." Thrombosis and Haemostasis 119, no. 7 (2019): 1171. https://doi.org/10.1055/s-0039-1688789.

MLA (9th ed.) Citation

Ubaid, Salahaddin, et al. "Cangrelor Versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial." Thrombosis and Haemostasis, vol. 119, no. 7, 2019, p. 1171, https://doi.org/10.1055/s-0039-1688789.